论文部分内容阅读
经过一年的争斗,万科股权之争已进入下半场。这场股权争斗将怎样收场?仍需拭目以待中国资本市场堪比商战大戏的“万宝之争”上演已整整一年多。2015年7月11日,万科首次公告指出,宝能系的前海人寿通过二级市场集中竞价买入万科A股5.53亿股股份,持股占比首达5.00%。而这也正是“万宝之争”的开端。但在一年后的今天看来,彼时的我们都只猜中了开头却没能猜中结尾,万科A股股价也早已经历了从14.48元涨至24.43元,再回调至目前的17.92元,价格变化幅度总和超过17元。
After a year of struggle, Vanke equity dispute has entered the second half. This stock market battle will be how to end? Still wary of China’s capital market comparable to the war drama “Wanbao dispute” staged a full year. July 11, 2015, Vanke’s initial announcement pointed out that Baoneng Department’s Qianhai Life through the secondary market focus bid to buy 553 million shares of Vanke A shares, the shareholding of up to 5.00%. And this is exactly the beginning of the Warlords. However, a year later today, when we just guess the beginning but did not guess the end, Vanke A share price has gone through from 14.48 yuan has risen to 24.43 yuan, and then call back to the current 17.92 yuan , The sum of price changes more than 17 yuan.